HSCI Faculty ‘extraordinary’ innovation recognized by the NIH
HSCI Principal Faculty members Jeffrey Macklis, Alex Schier and Brian Wainger were recently recognized ‘for exceptional creativity’ by the NIH’s High-Risk, High-Reward Research program. Jeff and Alex each received the NIH Director’s Pioneer Award which challenges investigators at all career levels to pursue new research directions and develop groundbreaking, high-impact approaches to a broad area of biomedical or behavioral science. Brian was bestowed the...
Press release of the Massachusetts General Hospital
Using human induced pluripotent stem cells (iPSCs), a Massachusetts General Hospital (MGH) research team has bioengineered functional small intestine segments that, when implanted into rats, were capable of deliver nutrients into the bloodstream. The investigators describe their accomplishment in the online journal Nature Communications.
“In this study we have been able to bridge the gap between differentiation of single cells – driving stem cells to become a specific cell type – and the...
Applications for 2018 Joslin Pilot & Feasibility grants now open to all Harvard/Affiliates.
The goal of the Pilot and Feasibility Study Program is to encourage research on diabetes and its complications by two target groups: young researchers in these fields who have not yet received significant NIH or other funding, and seasoned investigators either entering the diabetes field for the first time or exploring a completely new direction.
The program has been highly successful since its inception. Projects funded in past years...
...